KIR2DL4
Basic information
Region (hg38): 19:54803610-54814517
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the KIR2DL4 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 15 | 15 | ||||
missense | 31 | 34 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 2 | |||||
Total | 0 | 0 | 31 | 19 | 1 |
Variants in KIR2DL4
This is a list of pathogenic ClinVar variants found in the KIR2DL4 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-54803665-C-T | not specified | Uncertain significance (Nov 09, 2022) | ||
19-54803871-A-C | not specified | Benign (-) | ||
19-54803893-T-A | not specified | Uncertain significance (Jul 05, 2023) | ||
19-54803909-G-A | not specified | Uncertain significance (Jun 03, 2024) | ||
19-54803914-T-C | not specified | Uncertain significance (Dec 18, 2023) | ||
19-54803914-T-G | not specified | Uncertain significance (Mar 16, 2022) | ||
19-54803917-G-A | not specified | Uncertain significance (Mar 07, 2023) | ||
19-54803923-G-A | not specified | Uncertain significance (Jun 18, 2024) | ||
19-54804801-G-A | not specified | Uncertain significance (Oct 26, 2022) | ||
19-54804837-G-C | not specified | Uncertain significance (Mar 12, 2024) | ||
19-54804840-C-T | not specified | Uncertain significance (Apr 10, 2023) | ||
19-54804847-G-A | not specified | Uncertain significance (Mar 19, 2024) | ||
19-54804855-G-A | not specified | Uncertain significance (Jan 04, 2022) | ||
19-54804876-C-T | not specified | Uncertain significance (Aug 12, 2021) | ||
19-54804890-C-A | not specified | Uncertain significance (Aug 02, 2021) | ||
19-54804892-T-C | not specified | Uncertain significance (Sep 14, 2022) | ||
19-54804898-C-T | not specified | Uncertain significance (Sep 06, 2023) | ||
19-54804909-A-G | not specified | Likely benign (Mar 17, 2023) | ||
19-54804920-C-G | Likely benign (Aug 01, 2023) | |||
19-54804959-T-C | Likely benign (Aug 01, 2023) | |||
19-54804983-A-T | Likely benign (Aug 01, 2023) | |||
19-54804989-C-G | not specified | Uncertain significance (Feb 06, 2024) | ||
19-54805004-A-C | not specified | Uncertain significance (Jul 09, 2021) | ||
19-54805010-A-G | Likely benign (Aug 01, 2023) | |||
19-54805022-G-A | Likely benign (Aug 01, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
KIR2DL4 | protein_coding | protein_coding | ENST00000345540 | 7 | 89971 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0423 | 0.856 | 0 | 0 | 0 | 0 | 0.00 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.283 | 102 | 110 | 0.924 | 0.00000607 | 2177 |
Missense in Polyphen | 13 | 20.773 | 0.6258 | 535 | ||
Synonymous | 0.00817 | 41 | 41.1 | 0.998 | 0.00000245 | 672 |
Loss of Function | 1.33 | 3 | 6.74 | 0.445 | 3.25e-7 | 143 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Receptor on natural killer (NK) cells for HLA-C alleles. Inhibits the activity of NK cells thus preventing cell lysis.;
- Pathway
- Antigen processing and presentation - Homo sapiens (human);Natural killer cell mediated cytotoxicity - Homo sapiens (human);Cellular senescence - Homo sapiens (human);Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Adaptive Immune System
(Consensus)
Haploinsufficiency Scores
- pHI
- 0.0833
- hipred
- N
- hipred_score
- 0.380
- ghis
- 0.413
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.343
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- positive regulation of natural killer cell cytokine production;cellular defense response;signal transduction;negative regulation of natural killer cell mediated cytotoxicity;regulation of immune response;positive regulation of cellular senescence
- Cellular component
- plasma membrane;integral component of plasma membrane;membrane;early endosome membrane
- Molecular function
- transmembrane signaling receptor activity;protein binding;MHC class Ib receptor activity